Cargando…
The Studies of Prognostic Factors and the Genetic Polymorphism of Methylenetetrahydrofolate Reductase C667T in Thymic Epithelial Tumors
OBJECTIVE: To describe the clinical features of a cohort of patients with thymic epithelial tumors (TETs) and to analyze their prognostic factors. In particular, we investigated the correlation between the genetic polymorphism of methylenetetrahydrofolate reductase (MTHFR) C667T and the incidence of...
Autores principales: | Yan, Miaolong, Wu, Jiayuan, Xue, Min, Mo, Juanfen, Zheng, Li, Zhang, Jun, Gao, Zhenzhen, Bao, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207241/ https://www.ncbi.nlm.nih.gov/pubmed/35734597 http://dx.doi.org/10.3389/fonc.2022.847957 |
Ejemplares similares
-
Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer
por: Lin, Victor C., et al.
Publicado: (2016) -
Targeting mitochondrial one-carbon enzyme MTHFD2 together with pemetrexed confers therapeutic advantages in lung adenocarcinoma
por: Mo, Juanfen, et al.
Publicado: (2022) -
Methylenetetrahydrofolate Reductase Polymorphisms and Pregnancy Outcome
por: Turgal, Mert, et al.
Publicado: (2018) -
Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer
por: Campbell, Ian G, et al.
Publicado: (2002) -
Thiopurine S-Methyltransferase and Methylenetetrahydrofolate Reductase Polymorphisms in Leukemia
por: KÜPELİ, Serhan
Publicado: (2015)